|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dai X, Guo G, Zou P, Cui R, Chen W, Chen
X, Yin C, He W, Vinothkumar R, Yang F, et al: (S)-crizotinib
induces apoptosis in human non-small cell lung cancer cells by
activating ROS independent of MTH1. J Exp Clin Cancer Res.
36:1202017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mulshine JL and Sullivan DC: Clinical
practice. Lung cancer screening. N Engl J Med. 352:2714–2720. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Petschnigg J, Kotlyar M, Blair L, Jurisica
I, Stagljar I and Ketteler R: Systematic Identification of
Oncogenic EGFR Interaction Partners. J Mol Biol. 429:280–294. 2017.
View Article : Google Scholar :
|
|
6
|
Creutz CE, Tomsig JL, Snyder SL, Gautier
MC, Skouri F, Beisson J and Cohen J: The copines, a novel class of
C2 domain-containing, calcium-dependent, phospholipid-binding
proteins conserved from Paramecium to humans. J Biol Chem.
273:1393–1402. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomsig JL, Snyder SL and Creutz CE:
Identification of targets for calcium signaling through the copine
family of proteins. Characterization of a coiled-coil
copine-binding motif. J Biol Chem. 278:10048–10054. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomsig JL and Creutz CE: Biochemical
characterization of copine: A ubiquitous Ca2+-dependent,
phospholipid-binding protein. Biochemistry. 39:16163–16175. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park N, Yoo JC, Lee YS, Choi HY, Hong SG,
Hwang EM and Park JY: Copine1 C2 domains have a critical
calcium-independent role in the neuronal differentiation of
hippocampal progenitor HiB5 cells. Biochem Biophys Res Commun.
454:228–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Whittaker CA and Hynes RO: Distribution
and evolution of von Willebrand/integrin A domains: Widely
dispersed domains with roles in cell adhesion and elsewhere. Mol
Biol Cell. 13:3369–3387. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Asamura H, Chansky K, Crowley J, Goldstraw
P, Rusch VW, Vansteenkiste JF, Watanabe H, Wu YL, Zielinski M, Ball
D, et al: The International Association for the Study of Lung
Cancer Lung Cancer Staging Project: Proposals for the revision of
the N descriptors in the forthcoming 8th edition of the TNM
Classification for Lung Cancer. J Thorac Oncol. 10:1675–1684. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang H, Kirkness EF, Lippert C, Biggs WH,
Fabani M, Guzman E, Ramakrishnan S, Lavrenko V, Kakaradov B, Hou C,
et al: Profiling of short-tandem-repeat disease alleles in 12,632
human whole genomes. Am J Hum Genet. 101:700–715. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D,
Gu D, Huang JA and Liu Z: CD73/NT5E is a target of miR-30a-5p and
plays an important role in the pathogenesis of non-small cell lung
cancer. Mol Cancer. 16:342017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Tomsig JL and Creutz CE: Copines: A
ubiquitous family of Ca(2+)-dependent phospholipid-binding
proteins. Cell Mol Life Sci. 59:1467–1477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang J, Zhang J, Ruan J, Mi Y, Hu Q, Wang
Z and Wei B: CPNE1 is a useful prognostic marker and is associated
with TNF receptor-associated factor 2 (TRAF2) expression in
prostate cancer. Med Sci Monit. 23:5504–5514. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu C, Chen K, Zheng H, Guo X, Jia W, Li M,
Zeng M, Li J and Song L: Overexpression of astrocyte elevated
gene-1 (AEG-1) is associated with esophageal squamous cell
carcinoma (ESCC) progression and pathogenesis. Carcinogenesis.
30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu Y, Ju Q, Qian B, Zhang F and Shi H: The
effectiveness of PD-1 inhibitors in non-small cell lung cancer
(NSCLC) patients of different ages. Oncotarget. 9:7942–7948.
2017.
|
|
19
|
Nalefski EA and Falke JJ: The C2 domain
calcium-binding motif: Structural and functional diversity. Protein
Sci. 5:2375–2390. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rizo J and Südhof TC: C2-domains,
structure and function of a universal Ca2+-binding
domain. J Biol Chem. 273:15879–15882. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin HC, Zhang FL, Geng Q, Yu T, Cui YQ,
Liu XH, Li J, Yan MX, Liu L, He XH, et al: Quantitative proteomic
analysis identifies CPNE3 as a novel metastasis-promoting gene in
NSCLC. J Proteome Res. 12:3423–3433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi HY, Park N, Na JB, Ko ES, Park JY and
Yoo JC: Direct binding of Copine3 with Jab1 activates downstream
ErbB2 signaling and motility in SKBr3 breast cancer cells. Oncol
Rep. 35:1147–1152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heinrich C, Keller C, Boulay A, Vecchi M,
Bianchi M, Sack R, Lienhard S, Duss S, Hofsteenge J and Hynes NE:
Copine-III interacts with ErbB2 and promotes tumor cell migration.
Oncogene. 29:1598–1610. 2010. View Article : Google Scholar
|
|
24
|
Ciruelos Gil EM: Targeting the
PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer.
Cancer Treat Rev. 40:862–871. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miller TW, Rexer BN, Garrett JT and
Arteaga CL: Mutations in the phosphatidylinositol 3-kinase pathway:
Role in tumor progression and therapeutic implications in breast
cancer. Breast Cancer Res. 13:2242011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu Z, Yang H, Sutton MN, Yang M, Clarke
CH, Liao WS and Bast RC Jr: ARHI (DIRAS3) induces autophagy in
ovarian cancer cells by downregulating the epidermal growth factor
receptor, inhibiting PI3K and Ras/MAP signaling and activating the
FOXo3a-mediated induction of Rab7. Cell Death Differ. 21:1275–1289.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saini KS, Loi S, de Azambuja E,
Metzger-Filho O, Saini ML, Ignatiadis M, Dancey JE and
Piccart-Gebhart MJ: Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK
pathways in the treatment of breast cancer. Cancer Treat Rev.
39:935–946. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Britten CD: PI3K and MEK inhibitor
combinations: Examining the evidence in selected tumor types.
Cancer Chemother Pharmacol. 71:1395–1409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niméus-Malmström E, Koliadi A, Ahlin C,
Holmqvist M, Holmberg L, Amini RM, Jirström K, Wärnberg F,
Blomqvist C, Fernö M, et al: Cyclin B1 is a prognostic
proliferation marker with a high reproducibility in a
population-based lymph node negative breast cancer cohort. Int J
Cancer. 127:961–967. 2010.
|
|
30
|
Kedinger V, Meulle A, Zounib O, Bonnet ME,
Gossart JB, Benoit E, Messmer M, Shankaranarayanan P, Behr JP,
Erbacher P, et al: Sticky siRNAs targeting survivin and cyclin B1
exert an antitumoral effect on melanoma subcutaneous xenografts and
lung metastases. BMC Cancer. 13:3382013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matthess Y, Raab M, Sanhaji M, Lavrik IN
and Strebhardt K: Cdk1/cyclin B1 controls Fas-mediated apoptosis by
regulating caspase-8 activity. Mol Cell Biol. 30:5726–5740. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Soria JC, Jang SJ, Khuri FR, Hassan K, Liu
D, Hong WK and Mao L: Overexpression of cyclin B1 in early-stage
non-small cell lung cancer and its clinical implication. Cancer
Res. 60:4000–4004. 2000.PubMed/NCBI
|
|
33
|
Zhou L, Li J, Zhao YP, Cui QC, Zhou WX,
Guo JC, You L, Wu WM and Zhang TP: The prognostic value of Cyclin
B1 in pancreatic cancer. Med Oncol. 31:1072014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang F, Fu XD, Zhou Y and Zhang Y:
Down-regulation of the cyclin E1 oncogene expression by
microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB
Rep. 42:725–730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakayama N, Nakayama K, Shamima Y,
Ishikawa M, Katagiri A, Iida K and Miyazaki K: Gene amplification
CCNE1 is related to poor survival and potential therapeutic target
in ovarian cancer. Cancer. 116:2621–2634. 2010.PubMed/NCBI
|
|
36
|
Schraml P, Bucher C, Bissig H, Nocito A,
Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S, et
al: Cyclin E overexpression and amplification in human tumours. J
Pathol. 200:375–382. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu
Z, Zhao J and Zhang HT: JAK/STAT3 signaling is required for
TGF-β-induced epithelial-mesenchymal transition in lung cancer
cells. Int J Oncol. 44:1643–1651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ren F, Tang R, Zhang X, Madushi WM, Luo D,
Dang Y, Li Z, Wei K and Chen G: Overexpression of MMP family
members functions as prognostic biomarker for breast cancer
patients: A systematic review and meta-analysis. PLoS One.
10:e01355442015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ying TH, Lee CH, Chiou HL, Yang SF, Lin
CL, Hung CH, Tsai JP and Hsieh YH: Knockdown of Pentraxin 3
suppresses tumorigenicity and metastasis of human cervical cancer
cells. Sci Rep. 6:293852016. View Article : Google Scholar : PubMed/NCBI
|
